Sun Pharma Shares Dip 2.03% Amid Volume Surge; Financials Show Growth
Business
M
Moneycontrol•28-01-2026, 14:41
Sun Pharma Shares Dip 2.03% Amid Volume Surge; Financials Show Growth
- •Sun Pharmaceutical Industries shares declined by 2.03% to Rs 1,605.60 on Wednesday, experiencing a high trading volume.
- •The company reported a revenue of Rs 14,478.31 Crore and a net profit of Rs 3,137.09 Crore for the quarter ending September 2025.
- •Annual revenue for March 2025 reached Rs 52,578.44 Crore with a net profit of Rs 10,980.10 Crore, showing consistent growth.
- •The basic EPS for the year ending March 2025 was Rs 45.60, up from Rs 39.90 in the previous year.
- •Moneycontrol analysis indicates a very bearish sentiment for Sun Pharmaceutical Industries as of January 28, 2026, despite an announced interim dividend.
Why It Matters: Sun Pharma shares fell over 2% despite strong quarterly and annual financial performance, with bearish market sentiment.
✦
More like this
Loading more articles...
